Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

astrazeneca_sign_sky

AstraZeneca’s Imfinzi misses target in Phase III head and neck cancer trial

February 5, 2021
Medical Communications AstraZeneca, Cancer

AstraZeneca’s Imfinzi (durvalumab) has failed to improve overall survival (OS) for patients with recurrent or metastatic head and neck cancer …

News
astrazeneca-sign

China approves AstraZeneca’s heart failure drug Forxiga

February 4, 2021
AstraZeneca, Forxiga

AstraZeneca’s Forxiga (dapagliflozin) has been approved for use in China to reduce the risk of death and hospitalisation from heart …

News
astrazeneca_sign_sky

Longer Oxford-AstraZeneca vaccine interval improves efficacy, report says

February 3, 2021
Research and Development AstraZeneca, COVID-19

A longer interval between doses of the Oxford University-AstraZeneca vaccine could substantially improve efficacy, according to a report published in …

News
astrazeneca-sign

AstraZeneca COVID-19 vaccine not for over 65s, German health body says

January 29, 2021
Medical Communications AstraZeneca, COVID-19

Germany’s main public health body has recommended that AstraZeneca’s COVID-19 vaccine is only administered to those aged between 18 and …

News
astrazeneca_building_white

AstraZeneca rejects “incorrect” claims about COVID-19 vaccine efficacy

January 26, 2021
Manufacturing and Production AstraZeneca, COVID-19

AstraZeneca has rejected claims by German media that its COVID-19 vaccine has only 8% efficacy in over-65s. Two German newspapers, …

News
astrazeneca_sign_sky

EU approves breast cancer drug Enhertu

January 20, 2021
Research and Development AstraZeneca, Daiichi Sankyo

The EU has granted AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) conditional approval as a monotherapy for the treatment of …

News
astrazeneca_sign_sky

AstraZeneca’s Imfinzi gets EU and UK approval for new dosing option

January 15, 2021
Medical Communications AstraZeneca, Cancer, Imfinzi

AstraZeneca’s Imfinzi (durvalumab) has been approved in the EU and the UK for an additional dosing option in locally advanced, …

News
astrazeneca-sign

AstraZeneca seeks EU approval for COVID-19 vaccine

January 12, 2021
Manufacturing and Production AstraZeneca, COVID-19, Vaccine

AstraZeneca has applied for conditional marketing authorisation (CMA) from the EMA for its COVID-19 vaccine. CMA is used as the …

News

NICE recommends AstraZeneca’s FORXIGA for heart failure

January 7, 2021
AstraZeneca, NICE

NICE has issued a positive Final Appraisal Document (FAD) recommending AstraZeneca’s FORXIGA (dapagliflozin) as an option for treatment of symptomatic …

News
astrazeneca_sign_sky

AstraZeneca’s Farxiga granted Priority Review by FDA

January 6, 2021
Research and Development AstraZeneca, FDA, farxiga

AstraZeneca’s Farxiga (dapagliflozin) has been granted Priority Review in the US for the treatment of new or worsening chronic kidney …

News
astrazeneca-sign

UK becomes first country to roll out Oxford University-AstraZeneca COVID-19 vaccine

January 4, 2021
Sales and Marketing AstraZeneca, COVID-19, Vaccine

The UK has become the first country to administer the Oxford University-AstraZeneca COVID-19 vaccine to its population as coronavirus case …

News
astrazeneca_plaque

AstraZeneca’s cancer drug Tagrisso gets FDA approval

December 21, 2020
Sales and Marketing AstraZeneca, Cancer, FDA

The FDA has approved AstraZeneca’s Tagrisso (osimertinib) for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated …

News
astrazeneca_building_white

EMA panel recommends label extension of AstraZeneca’s Imfinzi in non-small cell lung cancer

December 15, 2020
Manufacturing and Production, Sales and Marketing AstraZeneca, Europe, Imfinzi, NSCLC

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has backed a new dosing regimen of AstraZeneca’s …

News
shutterstock_273326141

AstraZeneca to buy Alexion in $39 billion deal

December 14, 2020
Sales and Marketing Alexion, AstraZeneca, merger

British-Swedish AstraZeneca is set to acquire American biopharmaceutical company Alexion for $39 billion, in a move that will see a …

News
european_commission

European approval for AstraZeneca’s Trixeo Aerospace in moderate to severe COPD

December 14, 2020
Sales and Marketing AstraZeneca, COPD, EMA, Europe, Trixeo Aerosphere

The European Medicines Agency (EMA) has announced the approval of AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) in the European Union …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025